NCT06115707

Brief Summary

The aim of this trial is to investigate whether head elevation position after endovascular treatment can improve the 90-day functional outcome of acute large vessel occlusion in the anterior circulation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,368

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

67 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 30, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 3, 2023

Completed
10 days until next milestone

Study Start

First participant enrolled

November 13, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 26, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 26, 2025

Completed
Last Updated

November 28, 2025

Status Verified

October 1, 2025

Enrollment Period

1.5 years

First QC Date

October 30, 2023

Last Update Submit

November 26, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Modified Rankin scale score (mRS)

    disability level. The presence of impairments determines the transitions from mRS score 0 to mRS score 1 (symptoms) and mRS score 5 to mRS score 6 (death).

    90 days

Secondary Outcomes (12)

  • Proportion of patients non-disabled (mRS score 0 to 1) or return to pre-morbid mRS score at 90 days (for patients with mRS > 1)

    90 days

  • Proportion of patients functionally independent (mRS score 0 to 2) at 90 days

    Within 90 days90 days

  • Proportion of patients ambulatory or bodily needs-capable or better (mRS score 0 to 3)

    90 days

  • Health-related quality of life, assessed with the EuroQol-visual analogue scales (EQ-VAS)

    90 days

  • Mortality within 90 days

    90 days

  • +7 more secondary outcomes

Study Arms (2)

The lying flat group

ACTIVE COMPARATOR

Patients in lying flat intervention to be nursed lying flat (0°-10°) after endovascular therapy is made and to remain in this position for 72 hours.

Other: The lying flat (0°-10°) head position for 72 hours

The head elevation group

EXPERIMENTAL

Patients in the sitting up intervention should be nursed with their head elevated (30°-40°) by raising the head of the bed (or using extra pillows or wedges) after undergoing endovascular therapy, and to remain in this position for 72 hours.

Other: The The head elevation (30°-40°) position for 72 hours

Interventions

The lying flat (0°-10°) head position for 72 hours after endovascular therapy.

The lying flat group

The head elevoatin (30°-40°) position for 72 hours after endovascular therapy.

The head elevation group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical signs consistent with acute ischemic stroke;
  • Age ≥ 18 years old;
  • Proved anterior circulation large vessel occlusion on digital subtraction angiography (ICA, M1, M2) with/without cervical lesion (tandem);
  • NIHSS score ≥ 8 points before endovascular treatment;
  • ASPECTS score ≤ 7 points before endovascular treatment;
  • Successful vessel recanalization after endovascular treatment (defined as an eTICI score of 2b, 2c, or 3) ;
  • The time from onset to randomization ≤ 24 hours (the onset time is defined as the last normal time);
  • Written informed consent is obtained from patients and/or their legal representatives.

You may not qualify if:

  • Pre-stroke mRS score\>1 point;
  • Patients with acute occlusions in multiple vascular territories (e.g. bilateral anterior circulation, or anterior/posterior circulation);
  • Currently in pregnant or lactating or serum beta HCG test is positive on admission;
  • Contraindications to a flat head position;
  • Any terminal illness with life expectancy less than 6 months;
  • Participating in other clinical trials;
  • Patients with a preexisting neurological or psychiatric disease that would confound the neurological functional evaluations;
  • Unlikely to be available for 90-day follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (67)

Chongqing Banan District People's Hospital

Chongqing, Chongqing Municipality, China

Location

Chongqing Bishan District People's Hospital

Chongqing, Chongqing Municipality, China

Location

Chongqing Ninth People's Hospital

Chongqing, Chongqing Municipality, China

Location

Yongchuan Hospital Affiliated to Chongqing Medical University

Chongqing, Chongqing Municipality, China

Location

The First Affiliated Hospital of Fujian Medical University

Fuzhou, Fujian, China

Location

Longyan First Hospital

Longyan, Fujian, 364099, China

Location

Dingxi People's Hospital

Dingxi, Gansu, China

Location

Jiuquan People's Hospital

Jiuquan, Gansu, China

Location

Gansu Provincial Hospital of Traditional Chinese Medicine

Lanzhou, Gansu, China

Location

Lanzhou University First Hospital

Lanzhou, Gansu, China

Location

Lanzhou University Second Hospital

Lanzhou, Gansu, China

Location

Tianshui First People's Hospital

Tianshui, Gansu, China

Location

Zhujiang Hospital of Southern Medical University

Guanzhou, Guangdong, China

Location

Guangdong Provincial People's Hospital Heyuan Hospital

Heyuan, Guangdong, China

Location

Baise People's Hospital

Baise City, Guangxi, China

Location

Nanning Third People's Hospital

Nanning, Guangxi, China

Location

Qiannan Prefecture People's Hospital

Duyun, Guizhou, China

Location

Xingyi People's Hospital

Xingyi, Guizhou, China

Location

The First Affiliated Hospital of Hainan Medical College

Haikou, Hainan, China

Location

Jiamusi Central Hospital

Jiamusi, Heilongjiang, China

Location

Yichun First Hospital

Yichun, Heilongjiang, China

Location

Anyang People's Hospital

Anyang, Henan, China

Location

Xihua County People's Hospital

Zhoukou, Henan, China

Location

Shiyan taihe hospital

Shiyan, Hubei, China

Location

Ningxiang First People's Hospital

Changsha, Hunan, China

Location

The First People's Hospital of Chenzhou City

Chenzhou, Hunan, China

Location

Ganzhou Municipal Hospital

Ganzhou, Jiangxi, China

Location

Ganzhou People's Hospital

Ganzhou, Jiangxi, China

Location

Xingguo County People's Hospital

Ganzhou, Jiangxi, China

Location

Jiangxi Provincial People's Hospital

Nanchang, Jiangxi, China

Location

The First Hospital of Jilin University

Changchun, Jilin, China

Location

Dalian 967 Hospital

Dalian, Liaoning, China

Location

Ningxia Hui Autonomous Region People's Hospital

Yinchuan, Ningxia, China

Location

The Fifth People's Hospital of Qinghai Province

Xining, Qinghai, China

Location

Baoji High tech Hospital

Baoji, Shaanxi, China

Location

Northwest University Affiliated Hospital

Xi'an, Shaanxi, China

Location

Xidian Group Hospital

Xi'an, Shaanxi, China

Location

Xianyang First People's Hospital

Xianyang, Shaanxi, China

Location

Yulin First Hospital

Yulin, Shaanxi, China

Location

Rizhao Traditional Chinese Medicine Hospital

Rizhao, Shandong, China

Location

Shanxi Provincial Hospital

Taiyuan, Shanxi, China

Location

Chengdu Sixth People's Hospital

Chengdu, Sichuan, China

Location

Chongzhou People's Hospital

Chengdu, Sichuan, China

Location

Deyang People's Hospital

Deyang, Sichuan, China

Location

Guangyuan First People's Hospital

Guangyuan, Sichuan, China

Location

Affiliated Hospital of Southwest Medical University

Luzhou, Sichuan, 646000, China

Location

Gulin County People's Hospital

Luzhou, Sichuan, China

Location

Beichuan County People's Hospital

Mianyang, Sichuan, China

Location

Mianyang 404 Hospital

Mianyang, Sichuan, China

Location

Mianyang Central Hospital

Mianyang, Sichuan, China

Location

Affiliated Hospital of North Sichuan Medical College

Nanchong, Sichuan, China

Location

Neijiang Second People's Hospital

Neijiang, Sichuan, China

Location

Suining Central Hospital

Suining, Sichuan, China

Location

Suining First People's Hospital

Suining, Sichuan, China

Location

Liangshan First People's Hospital

Xichang, Sichuan, China

Location

Xichang People's Hospital

Xichang, Sichuan, China

Location

Ya'an People's Hospital

Ya'an, Sichuan, China

Location

Yibin Second People's Hospital

Yibin, Sichuan, China

Location

Fushun County People's Hospital

Zigong, Sichuan, China

Location

Zigong First People's Hospital

Zigong, Sichuan, China

Location

Zigong Fourth People's Hospital

Zigong, Sichuan, China

Location

Zigong Third People's Hospital

Zigong, Sichuan, China

Location

The Seventh Affiliated Hospital of Xinjiang Medical University

Ürümqi, Xinjiang, China

Location

The First Affiliated Hospital of Kunming Medical University

Kunming, Yunnan, China

Location

The Second Affiliated Hospital of Kunming Medical University

Kunming, Yunnan, China

Location

Qujing First People's Hospital

Qujing, Yunnan, China

Location

Wenzhou Medical University First Affiliated Hospital

Wenzhou, Zhejiang, China

Location

MeSH Terms

Conditions

Stroke

Interventions

Patient Positioning

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Patient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Zhengzhou Yuan

    Affiliated Hospital of Southwest Medical University

    STUDY CHAIR
  • Yong Jiang

    Affiliated Hospital of Southwest Medical University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

October 30, 2023

First Posted

November 3, 2023

Study Start

November 13, 2023

Primary Completion

April 26, 2025

Study Completion

April 26, 2025

Last Updated

November 28, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations